MedPath

Comparison examination of microbiota in mouth, intestine and vagina before and after medication of a raw bacillus agent (an active bacterial probiotics, Bio-Three) to the threatened premature delivery patient who requires in-hospital treatment, and examination about validity of preterm delivery medical treatment

Not Applicable
Completed
Conditions
threatened preterm delivery
Registration Number
JPRN-UMIN000016860
Lead Sponsor
niversity of Toyama
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) multiple pregnancy 2) previous medication of antibiotics within 14 days 3) premature rupture of the membranes 4) tocolysis index of 7 or higher (there is a possibility of becoming a preterm delivery within one week) 5) allergy to Bio-Three 6) ulcerative colitis and Crohn's disease

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a change of microbiota in mouth, intestine and vagina
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath